How to Hack a $1.3T Market
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Financials
| Curr Year EPS Estimate | 4.60 |
| Next Quarter EPS Estimate | 0.95 |
| Profit Margin | 13.54% |
| Operating Margin | 23.14 |
| Return on Assets | 0.04 |
| Return on Equity | 0.07 |
| Revenue | 44.4B |
| Earnings Per Share | 2.95 |
| Revenue Per Share | 18.10 |
| Gross Profit | 32,050,999,296 |
| Quarterly Revenue Growth | -0.05 |
General
| Name | Sanofi ADR |
| Ticker | SNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 82,878 |
About Sanofi ADR
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines. In addition, the company has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as an strategic alliance with the Department of Health " Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incor
Dividend
Sanofi ADR pays out a dividend of $2.38 per share, with a dividend yield of 4.92%.
SNY's last dividend payment was made to shareholders on June 12, 2025.
They pay out 66.53% of their earnings out as a dividend.
Recent Dividends
| Jun 12, 2025 | $2.21 |
| Jun 6, 2024 | $2.04 |
Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not
WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.
Cathie Wood's Alpha Surge: $250 Million Circle Windfall, Big AMD Buys
Cathie Wood, founder and CEO of ARK Invest, has recently been on a hot streak of successful and high-profile trades through her flagship ARK ETFs.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Cargo ship carrying new vehicles to Mexico sinks in the North Pacific weeks after catching fire
ANCHORAGE, Alaska (AP) — A cargo ship that had been delivering new vehicles to Mexico sank in the North Pacific Ocean, weeks after crew members abandoned ship when they couldn’t extinguish an onboard fire that left the carrier dead in the water.
Mystery Seller Behind $105 Million Plot Next to Jeff Bezos Estate Finally Revealed
A plot of land neighboring Jeff Bezos' property in Miami was sold for a staggering $105 million. The undeveloped lot was sold by German investor Mikhail Peleg.
How High Will Gold Surge? - Ad
Gold is on fire - hitting $3,500 and outpacing stocks, tech, even Bitcoin. Analyst Sean Brodrick called it, and now he's forecasting a surge to $6,900. But the biggest opportunity isn't bullion. It's a little-known investment that's returned up to 1,000x more than physical gold.
Greenland has a message for the rest of the world: Come visit
NUUK, Greenland (AP) — has a message for the rest of the world: We’re waiting for you.
After Diddy's conviction, here's where his business ventures stand
LOS ANGELES (AP) — Sean “Diddy” Combs has been in his federal sex trafficking trial, but that doesn't mean the once-celebrated music mogul will see his business empire restored.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Trump's Tariffs, Boeing's Blowout, Tesla's Robotaxi, BYD's European Triumph And GM's Massive Recall: This Week In Mobility
This week's business and finance highlights include Japan's rejection of Trump's auto tariffs, Boeing's scrutiny over a mid-air incident, Tesla's Robotaxi launch, BYD's dominance in Europe, and GM's massive vehicle recall.
Sig Sauer, faced with lawsuits over a popular pistol, gets protection in New Hampshire
CONCORD, N.H. (AP) — Faced with mounting lawsuits over a popular pistol, New Hampshire-based Sig Sauer asked for — and got — protection in the form of a new state law that makes it harder to .
The Missing Ingredient for Big Tech's $3T Recipe? - Ad
Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.
Elon Musk Says 'Clear Path' To Restoring Hearing With Neuralink, But The Deaf Community Want To Have Their 'Say'
Elon Musk's Neuralink faces backlash from the deaf community after proposing brain implant technology to restore hearing, with deaf adults calling for inclusion in the research process.
Dave Ramsey Has Blunt Advice On How Much To Spend To Keep A Pet Dog Alive: 'I've Seen People Spend Tens Of Thousands Of Dollars…'
Dave Ramsey offers tough advice to pet owners facing financial difficulties. He advises against going into debt to keep pets alive.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
North Koreans swim and play at a beach resort touted as a boost for tourism
SEOUL, South Korea (AP) — North Koreans swam, rode water park slides and enjoyed other water activities at a newly opened state media reported Wednesday, as the country largely maintains a ban on the entry of foreign tourists.
What's in the latest version of Trump's big bill moving through the Senate
WASHINGTON (AP) — Republicans are inching closer to getting their tax and spending cut bill through Congress with a final Senate vote likely late Monday or early Tuesday.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.
Trump Brokers Peace Deal Between DR Congo And Rwanda — Now Eyes Billions In US Investment
Trump brokers a peace deal between DR Congo and Rwanda, aiming to end conflict and unlock U.S. investment in critical African minerals.
The Unlikely Duo Rethinking Wearable Technology - Ad
Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.
Boeing Rises 2.8% After Key Trading Signal
A significant trading signal occurred for Boeing stock, as it demonstrated a power inflow at $209.02, after which BA rose up to 2.8%.
A hard-right lawmaker is sworn in as Greece's migration minister
ATHENS, Greece (AP) — A hard-right lawmaker was sworn in Monday as Greece’s migration minister, replacing a fellow right-wing political heavyweight who resigned following
Trump's Exec Order #14154 Could Be a "Millionaire-Maker" - Ad
Trump's next move could cement his legacy--and trigger a historic wealth boom. Ex-presidential advisor Jim Rickards reveals how it could hand millions a shot at true financial freedom. Watch the urgent interview while it's still free.
Amy Coney Barrett Earns Trump's Credit After Court Ruling: 'I Have Great Respect For Her'
Trump praises Justice Barrett's Supreme Court ruling limiting nationwide injunctions, while blasting NYC's Mamdani and defending his economic agenda.
Business News Digest
AP Business Digest
A Historic Gold Announcement Is About to Rock Wall Street - Ad
The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.
US Stocks Likely To Open Higher, Continuing Record-Setting Advances: June Has Never Seen An All-Time High Since 1950, Highlights Expert
U.S. futures rose on Monday after a record close on Friday. Futures of major benchmark indices were trading higher.
Spanish court rejects Airbnb appeal and keeps order to block nearly 66,000 listings
MADRID (AP) — A Spanish court on Thursday rejected an appeal by Airbnb and left in place an order to block almost 66,000 rental listings that the government said violated local rules.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Ivy League MBA Was A 'Waste Of Time,' Says Veteran Banker, Lists Two Key Traits Far More Relevant In The AI Age
Standard Chartered CEO Bill Winters says his MBA was a waste of time, and today's leaders need curiosity and empathy, not just technical skills.
Kevin O'Leary Once Said That Business School Graduates Know Nothing Until The Real World Smacks Them, Something He Learned The Hard Way— Now He Can Spot A Winner In 15 Minutes Flat
Kevin O'Leary says real-world experience—not business school—taught him to trust his intuition, which now allows him to spot winning entrepreneurs in just 15 minutes with near-perfect accuracy.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Musk Third-Party Odds Hit 47% — Can The Tesla Chief Do What No One Has Since 1853?
A promise to create a third party from billionaire Elon Musk comes with historical difficulties of challenging the current two-party system.
Occidental Petroleum, Exxon Mobil, Chevron Surge In Monday Pre-Market: What's Going On?
Occidental Petroleum Corp (NYSE: OXY), Exxon Mobil Corp (NYSE: XOM) and Chevron Corp (NYSE: CVX) climbed 1.95%, 1.53% and 1.31% during Monday pre-market trading session after oil prices have skyrocketed to their highest point since January, sparking concerns about potential supply disruptions.
How High Will Gold Surge? - Ad
Gold is on fire - hitting $3,500 and outpacing stocks, tech, even Bitcoin. Analyst Sean Brodrick called it, and now he's forecasting a surge to $6,900. But the biggest opportunity isn't bullion. It's a little-known investment that's returned up to 1,000x more than physical gold.
Iran's Top Diplomat To UN Says Uranium Enrichment To Continue: An 'Inalienable Right'
Iran reaffirms commitment to nuclear program despite US strikes. Ambassador cites Non-Proliferation Treaty as justification. Impact remains debated.
Apple Has the Potential To Crush Meta's Ray-Ban Smart Glasses, Says Ming-Chi Kuo, But The Tech Giant Has Been 'Surprisingly Slow'
Analyst Ming-Chi Kuo believes Apple has the potential to surpass Meta's Ray-Ban smart glasses, but notes the company's slow progress in this market could delay its dominance.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Goldman Just Launched Two New Bond ETFs; Here's Why Investors Should Pay Attention
Goldman Sachs Asset Management debuts two new actively managed fixed income ETFs in response to rising demand for active strategies in a volatile rate landscape.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.